부산대학교 도서관

Flint AC; Department of Neuroscience, Kaiser Permanente, Redwood City, CA, USA.; Rao VA; Department of Neuroscience, Kaiser Permanente, Redwood City, CA, USA.; Chan SL; Department of Neuroscience, Kaiser Permanente, Redwood City, CA, USA.; Cullen SP; Department of Neuroscience, Kaiser Permanente, Redwood City, CA, USA.; Faigeles BS; Department of Neuroscience, Kaiser Permanente, Redwood City, CA, USA.; Smith WS; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; Bath PM; Division of Stroke, University of Nottingham, Nottingham, UK.; Wahlgren N; Department of Clinical Neurosciences, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Ahmed N; Department of Clinical Neurosciences, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Donnan GA; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.; Johnston SC; Dell Medical School, University of Texas, Austin, TX, USA.

Publisher: SAGE Publications Country of Publication: United States NLM ID: 101274068 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4949 (Electronic) Linking ISSN: 17474930 NLM ISO Abbreviation: Int J Stroke Subsets: MEDLINE

Chan, WS; Chunilal, SD; Bates, S; Naguit, I; Sood, R; Johnston, M; Ginsberg, JS

BLOOD; NOV 15 1999, 94 10, p20A-p20A, 1p. Supplement: 1

Berger AM; Mooney K; Alvarez-Perez A; Breitbart WS; Carpenter KM; Cella D; Cleeland C; Dotan E; Eisenberger MA; Escalante CP; Jacobsen PB; Jankowski C; LeBlanc T; Ligibel JA; Loggers ET; Mandrell B; Murphy BA; Palesh O; Pirl WF; Plaxe SC; Riba MB; Rugo HS; Salvador C; Wagner LI; Wagner-Johnston ND; Zachariah FJ; Bergman MA; Smith C

Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

Johnston, SC; Halbach, VV; Smith, WS; Gress, DR

NEUROLOGY; JAN 15 1999, 52 2, p430-p430, 1p.

Griessenauer CJ; Departments of 1 Neurosurgery and.; Lebensburger JD; Pediatric Hematology Oncology, University of Alabama at Birmingham, Alabama; and.; Chua MH; Harvard Medical School, Boston, Massachusetts.; Fisher WS 3rd; Departments of 1 Neurosurgery and.; Hilliard L; Pediatric Hematology Oncology, University of Alabama at Birmingham, Alabama; and.; Bemrich-Stolz CJ; Pediatric Hematology Oncology, University of Alabama at Birmingham, Alabama; and.; Howard TH; Pediatric Hematology Oncology, University of Alabama at Birmingham, Alabama; and.; Johnston JM; Departments of 1 Neurosurgery and.

Publisher: American Association of Neurological Surgeons Country of Publication: United States NLM ID: 101463759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1933-0715 (Electronic) Linking ISSN: 19330707 NLM ISO Abbreviation: J Neurosurg Pediatr Subsets: MEDLINE

Awan, AN; Hays, WS; Jamal, M; Arora, S; Glew, RH; Johnston, DE

GASTROENTEROLOGY; APR 15 1998, 114 4, pA864-pA865, 2p. Supplement: S

Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.; Catton CN; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.; Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Payne H; The Prostate Centre, London, UK.; Forcat S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Goldstein C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Murphy C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Anderson J; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Branagan J; Northampton General Hospital, Northampton, UK.; Choudhury A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Chung PWM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Cogley L; Derriford Hospital, Plymouth, UK.; Goh CL; Royal Surrey Hospital, Guildford, UK.; Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK; Mount Vernon Cancer Centre, Northwood, UK.; Khoo V; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.; Masters L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.; Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.; Tarver KL; Department of Oncology, Queen's Hospital, Romford, UK.; Tree AC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Wylie JP; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Smarr, KL; Parker, JC; Slaughter, JR; Johnston, SK; Priesmeyer, ML; Wright, GE; Buchholz, JL; Hewett, JE; Walker, SE; Irvin, WS; Reddy, GK

ARTHRITIS AND RHEUMATISM; SEP 1998, 41 9, pS295-pS295, 1p. Supplement: S

Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.; Catton CN; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.; Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Pugh CA; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Payne H; The Prostate Centre, London, UK.; Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Brawley C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Rauchenberger M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Rigshospitalet, Copenhagen, Denmark.; Chung HT; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Chung PWM; Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Conroy R; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Falconer A; Radiotherapy Department, Charing Cross Hospital, London, UK.; Ford V; Royal Devon and Exeter University NHS Foundation Trust, Exeter, UK.; Goh CL; Royal Surrey County Hospital, Guildford, UK.; Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.; James ND; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Kim-Sing C; Department of Radiation Oncology, BC Cancer-Vancouver, Vancouver, BC, Canada.; Kodavatiganti R; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Bangor, UK.; Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.; Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.; Rodda S; Bradford Teaching Hospitals, Bradford, UK.; Wells P; Barts Cancer Centre, St Bartholomew's Hospital, London, UK.; Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Hays, WS; VanderJagt, DJ; Glew, RH; Johnston, DE; Eghtesad, B

HEPATOLOGY; OCT 1998, 28 4, p607A-p607A, 1p. Supplement: S